RAP1GDS1 Antikörper (C-Term)
-
- Target Alle RAP1GDS1 Antikörper anzeigen
- RAP1GDS1 (RAP1, GTP-GDP Dissociation Stimulator 1 (RAP1GDS1))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RAP1GDS1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Affinity purification
- Immunogen
- C-terminal region of human RAP1GDS1
- Top Product
- Discover our top product RAP1GDS1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01 % Sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- RAP1GDS1 (RAP1, GTP-GDP Dissociation Stimulator 1 (RAP1GDS1))
- Andere Bezeichnung
- RAP1GDS1 (RAP1GDS1 Produkte)
- Synonyme
- GDS1 antikoerper, SmgGDS antikoerper, BC011279 antikoerper, XsmgGDS antikoerper, gds1 antikoerper, rap1gds1 antikoerper, smgGDS antikoerper, Rap1 GTPase-GDP dissociation stimulator 1 antikoerper, RAP1, GTP-GDP dissociation stimulator 1 antikoerper, RAP1, GTP-GDP dissociation stimulator 1 L homeolog antikoerper, Rap1gds1 antikoerper, RAP1GDS1 antikoerper, rap1gds1.L antikoerper
- Molekulargewicht
- 66 kDa
- UniProt
- P52306
- Pathways
- SARS-CoV-2 Protein Interaktom
-